Drug delivery vs drops: Controlling postop pain, inflammation in cataract surgery patients
December 8th 2020John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.
Read More
CMS approves physician fee schedule, including Medicare cuts to ophthalmology
December 7th 2020The Centers for Medicare and Medicaid Services has released its final physician fee schedule for 2021. Despite opposition from the American Academy of Ophthalmology, the schedule includes an overall cut of 6% to ophthalmology.
Read More
Robert Jampel, MD, PhD, former director of Kresge Eye Institute, dies at 94
December 2nd 2020During his 24-year tenure as chair of the Wayne State University School of Medicine’s department of ophthalmology and director of the Kresge Eye Institute, Dr. Jampel oversaw the growth of the department.
Read More
Single administration of intracameral bimatoprost implant: IOP lowering, safety
December 2nd 2020Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.
Read More
Integrating AI to manage DR in a primary care setting
December 1st 2020Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.
Read More
(AAO) Study confirms Phase III results for uveitis treatment
November 14th 2020Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.
Read More
(AAO) Bringing high-level content to a virtual audience
November 13th 2020Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.
Read More
Medical professionals urge Congress to retain Medicare sequester pause
October 27th 2020Congress paused Medicare sequester cuts to offer relief amid the pandemic. Now, the leaders of the American Medical Association, American Hospital Association, American Health Care Association, and National Association for Home Care & Hospice are urging congressional leadership to keep the pause in place.
Read More
COVID-19: Practices falling short of pre-pandemic levels
October 2nd 2020Primary care has yet to regain the strength it had before the COVID-19 pandemic, according to a study released recently by the Larry A. Green Center, a research organization, in collaboration with the Primary Care Collaborative.
Read More
Tattoo you: Scleral tattoos pose threat to eye health
September 29th 2020A French kindergarten teacher has lost his job after the parents of a child complained about his appearance, which includes multiple face tattoos, including the sclera of his eyes, which have been turned to black by the ink. Scleral tattoos pose a serious threat to eye health, and could be a challenge for ophthalmologists treating these patients.
Read More
COVID-19 pandemic driving jump in Medicaid enrollment
September 9th 2020According to an analysis of Medicaid enrollment data during the coronavirus disease 2019 (COVID-19) pandemic, there has been an increase in enrollment during the crisis. This shift is likely to have a ripple effect throughout the healthcare landscape, including ophthalmology.
Read More
Survey: Pandemic could leave children with less access to ophthalmologists
September 5th 2020A survey by the American Association of Pediatric Ophthalmology and Strabismus found that the COVID-19 pandemic could leave some pediatric ophthalmology practices highly strained, possibly beyond repair.
Read More
Researchers developing antiviral drug for COVID-19
August 31st 2020Investigators with the Texas Tech University Health Sciences Center Department of Ophthalmology and Visual Sciences have filed a US patent for a novel peptide that uses selenium as a catalyst to target vulnerable areas of coronaviruses, including COVID-19.
Read More